ArticleInvestigational new drugs2020

A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.

Sagar Sardesai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.